Cardiovascular effects of dynorphin A (1–13) in conscious rats and its modulation of morphine bradycardia over time
- 1 November 1987
- Vol. 8 (6) , 1089-1092
- https://doi.org/10.1016/0196-9781(87)90141-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Central and peripheral sites for cardiovascular actions of dynorphin-(1–13) in ratsEuropean Journal of Pharmacology, 1985
- ICI 174864, a putative δ opioid antagonist, reverses endotoxemic hypotension: Pretreatment with dynorphin 1–13, a κ agonist, blocks this actionNeuropeptides, 1984
- Possible regulatory function of dynorphin and its clinical implicationsTrends in Pharmacological Sciences, 1984
- Peripheral opioid receptors influencing heart rate in rats: evidence for endogenous toleranceRegulatory Peptides, 1984
- Cardiovascular Effects of Endogenous Opiate SystemsAnnual Review of Pharmacology and Toxicology, 1983
- Differential cardiovascular effects of μ, δ and κ opiate agonists at discrete hypothalamic sites in the anesthetized ratLife Sciences, 1982
- Cardiorespiratory effects of μ and δ opiate agonists following third or fourth ventricular injectionsPeptides, 1982
- Dynorphin(1–13), a long-lasting inhibitor of opiate receptor binding invitroLife Sciences, 1982
- Naloxone reversal of endotoxin hypotension suggests role of endorphins in shockNature, 1978
- Hyperalgesia Induced by Naloxone Follows Diurnal Rhythm in Responsivity to Painful StimuliScience, 1977